
John M. Bedtelyon
Examiner (ID: 7721, Phone: (571)270-1290 , Office: P/2874 )
| Most Active Art Unit | 2874 |
| Art Unit(s) | 2874 |
| Total Applications | 1080 |
| Issued Applications | 839 |
| Pending Applications | 63 |
| Abandoned Applications | 198 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8649646
[patent_doc_number] => 20130035376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-07
[patent_title] => 'MCP-1 binding nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 13/487341
[patent_app_country] => US
[patent_app_date] => 2012-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 39232
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13487341
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/487341 | MCP-1 binding nucleic acids | Jun 3, 2012 | Issued |
Array
(
[id] => 9477265
[patent_doc_number] => 20140134728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'METHODS FOR ADJUSTING EXPRESSION OF MITOCHONDRIAL GENOME BY MICRORNA'
[patent_app_type] => utility
[patent_app_number] => 14/122716
[patent_app_country] => US
[patent_app_date] => 2012-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17009
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122716
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/122716 | METHODS FOR ADJUSTING EXPRESSION OF MITOCHONDRIAL GENOME BY MICRORNA | May 31, 2012 | Abandoned |
Array
(
[id] => 8611960
[patent_doc_number] => 20130017272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'METHOD FOR TREATING NON-SMALL CELL LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/475780
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 29980
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475780
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/475780 | METHOD FOR TREATING NON-SMALL CELL LUNG CANCER | May 17, 2012 | Abandoned |
Array
(
[id] => 10870608
[patent_doc_number] => 08895806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-25
[patent_title] => 'Fucosyl transferase gene'
[patent_app_type] => utility
[patent_app_number] => 13/471759
[patent_app_country] => US
[patent_app_date] => 2012-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 23
[patent_no_of_words] => 11326
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13471759
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/471759 | Fucosyl transferase gene | May 14, 2012 | Issued |
Array
(
[id] => 8995021
[patent_doc_number] => 08518905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment of prevention of toll-like receptor-4-associated disorders'
[patent_app_type] => utility
[patent_app_number] => 13/461672
[patent_app_country] => US
[patent_app_date] => 2012-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 85
[patent_no_of_words] => 9948
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13461672
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/461672 | Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment of prevention of toll-like receptor-4-associated disorders | Apr 30, 2012 | Issued |
Array
(
[id] => 8347954
[patent_doc_number] => 20120208864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF GCGR'
[patent_app_type] => utility
[patent_app_number] => 13/457960
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 137645
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13457960
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/457960 | COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF GCGR | Apr 26, 2012 | Abandoned |
Array
(
[id] => 10115995
[patent_doc_number] => 09150867
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-06
[patent_title] => 'DNA aptamers for promoting remyelination'
[patent_app_type] => utility
[patent_app_number] => 14/114392
[patent_app_country] => US
[patent_app_date] => 2012-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8347
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114392
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/114392 | DNA aptamers for promoting remyelination | Apr 24, 2012 | Issued |
Array
(
[id] => 9166893
[patent_doc_number] => 08592571
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-26
[patent_title] => 'RNAi modulation of APOB and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/450886
[patent_app_country] => US
[patent_app_date] => 2012-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 41215
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13450886
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/450886 | RNAi modulation of APOB and uses thereof | Apr 18, 2012 | Issued |
Array
(
[id] => 9384692
[patent_doc_number] => 20140088174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'COMPOUNDS AND METHODS FOR ALTERING ACTIVIN RECEPTOR-LIKE KINASE SIGNALING'
[patent_app_type] => utility
[patent_app_number] => 14/110036
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 22771
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110036
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110036 | COMPOUNDS AND METHODS FOR ALTERING ACTIVIN RECEPTOR-LIKE KINASE SIGNALING | Apr 4, 2012 | Abandoned |
Array
(
[id] => 11250552
[patent_doc_number] => 09476043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Diagnosis and treatment of friedreich\'s ataxia'
[patent_app_type] => utility
[patent_app_number] => 14/110558
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11429
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110558
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110558 | Diagnosis and treatment of friedreich's ataxia | Apr 3, 2012 | Issued |
Array
(
[id] => 9491039
[patent_doc_number] => 20140141446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'Aptamers That Are Specific for Immunoglobulin-Binding Cell Wall Proteins'
[patent_app_type] => utility
[patent_app_number] => 14/009088
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18117
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009088
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/009088 | Aptamers that are specific for immunoglobulin-binding cell wall proteins | Mar 28, 2012 | Issued |
Array
(
[id] => 8290593
[patent_doc_number] => 20120178917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'RNA APTAMERS AND METHODS FOR IDENTIFYING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/428352
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 31416
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13428352
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/428352 | RNA APTAMERS AND METHODS FOR IDENTIFYING THE SAME | Mar 22, 2012 | Abandoned |
Array
(
[id] => 10505262
[patent_doc_number] => 09233121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-12
[patent_title] => 'Compositions and methods for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 13/984411
[patent_app_country] => US
[patent_app_date] => 2012-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 29
[patent_no_of_words] => 11415
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984411
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/984411 | Compositions and methods for the treatment of cancer | Mar 11, 2012 | Issued |
Array
(
[id] => 8394282
[patent_doc_number] => 20120232125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'MODULATION OF DIACYLGLYCEROL ACYLTRANSFERASE 1 EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 13/414614
[patent_app_country] => US
[patent_app_date] => 2012-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26883
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13414614
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/414614 | MODULATION OF DIACYLGLYCEROL ACYLTRANSFERASE 1 EXPRESSION | Mar 6, 2012 | Abandoned |
Array
(
[id] => 11809078
[patent_doc_number] => 09713636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-25
[patent_title] => 'Nucleic acid/polysaccharide complex'
[patent_app_type] => utility
[patent_app_number] => 14/001694
[patent_app_country] => US
[patent_app_date] => 2012-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14950
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001694
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/001694 | Nucleic acid/polysaccharide complex | Feb 14, 2012 | Issued |
Array
(
[id] => 8312534
[patent_doc_number] => 20120189555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'METHODS AND COMPOSITIONS FOR PREVENTION OR TREATMENT OF RSV INFECTION'
[patent_app_type] => utility
[patent_app_number] => 13/359421
[patent_app_country] => US
[patent_app_date] => 2012-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 35156
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13359421
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/359421 | Methods and compositions for prevention or treatment of RSV infection | Jan 25, 2012 | Issued |
Array
(
[id] => 9869240
[patent_doc_number] => 08957012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-17
[patent_title] => 'Gamma secretase inhibitor for treatment of herpesvirus infection'
[patent_app_type] => utility
[patent_app_number] => 13/357452
[patent_app_country] => US
[patent_app_date] => 2012-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 18
[patent_no_of_words] => 18225
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13357452
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/357452 | Gamma secretase inhibitor for treatment of herpesvirus infection | Jan 23, 2012 | Issued |
Array
(
[id] => 8227804
[patent_doc_number] => 20120142008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'METHODS FOR EVALUATING GASTROINTESTINAL ABSORPTION OF CHEMICALS'
[patent_app_type] => utility
[patent_app_number] => 13/347544
[patent_app_country] => US
[patent_app_date] => 2012-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26035
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13347544
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/347544 | METHODS FOR EVALUATING GASTROINTESTINAL ABSORPTION OF CHEMICALS | Jan 9, 2012 | Abandoned |
Array
(
[id] => 10888159
[patent_doc_number] => 08912155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-16
[patent_title] => 'Method for analyzing secretome, biomarker for lung cancer metastasis, and siRNA compound for inhibiting lung cancer metastasis'
[patent_app_type] => utility
[patent_app_number] => 13/338020
[patent_app_country] => US
[patent_app_date] => 2011-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4838
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13338020
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/338020 | Method for analyzing secretome, biomarker for lung cancer metastasis, and siRNA compound for inhibiting lung cancer metastasis | Dec 26, 2011 | Issued |
| 13/329095 | ANTISENSE MODULATION OF CONNECTIVE TISSUE GROWTH FACTOR EXPRESSION | Dec 15, 2011 | Abandoned |